aTyr Pharma Inc. (NASDAQ: LIFE) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ATYR PHARMA INC.

aTyr Pharma Inc. (NASDAQ: LIFE)
Listen to this Section


$16.69
-0.4900 ( -2.85% ) 184.0K

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Market Data


Open $16.69
Previous Close $17.18
Volume 184.0K
Market Cap $1.06B
Day Range $16.59 - $18.13
52 Week Range $9.45 - $32.50
Shares Outstanding 62.99M
Change % -2.85%
Net Change ▼ -0.4900
Insider Ownership -0.01%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
IPO Year2026
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -253,338.00

Date Type Amount Purchased Purchaser
2025-10-09 Buy 682001.00 SCHIMMEL PAUL
2024-07-24 Buy 41052.00 SCHIMMEL PAUL
2024-06-06 Buy 5000.00 DENYES NANCY
2024-06-03 Buy 20000.00 Shukla Sanjay
2024-06-03 Buy 5000.00 Broadfoot Jill Marie
2024-06-03 Buy 50000.00 COUGHLIN TIMOTHY
2024-05-23 Sale -24000.00 SCHIMMEL PAUL
2024-05-23 Sale -24000.00 Lucas Svetlana
2024-05-23 Sale -24000.00 Gross Jane A
2024-05-23 Sale -24000.00 Zaknoen Sara

SEC Filings


Form Type Description Pages Date
8-k 8K-related 12 Nov 06, 2025
10-q Quarterly Reports 52 Nov 06, 2025
4 Insider transactions 1 Oct 09, 2025
8-k 8K-related 22 Sep 15, 2025
8-k/a 8K-related 12 Aug 08, 2025
8-k 8K-related 12 Aug 07, 2025
10-q Quarterly Reports 55 Aug 07, 2025

Latest News


× Before browsing our site, please accept our cookies policy